Skip to main content

H.C. Wainwright

CytoSorbents Execs to Present at H.C. Wainwright Investor Conference

CytoSorbents Execs to Present at H.C. Wainwright Investor Conference

Princeton, N.J. – – September 15, 2026 -- CytoSorbents Corporation (NASDAQ: CTSO) will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City from September 14–16, 2026, as the blood-purification device maker seeks to update investors on its regulatory pipeline and path to profitability.

CEO and CFO to join fireside chat on September 14

Dr. Phillip Chan, Chief Executive Officer, and Peter Mariani, Chief Financial Officer, will join Sean Lee, Vice President of Equity Research at H.C. Wainwright, for a fireside chat at 11:30 a.m. EDT at the Lotte New York Palace Hotel. The two executives will also hold scheduled one-on-one meetings with investors during the three-day event. A webcast replay will remain archived for up to 90 days on the company's investor relations site.

TEN Holdings CEO to Pitch Growth Strategy at H.C. Wainwright Conference

TEN Holdings CEO to Pitch Growth Strategy at H.C. Wainwright Conference

Langhorne, Pa. – September 12, 2026 -- TEN Holdings, Inc. (Nasdaq: XHLD) will present at the H.C. Wainwright 28th Annual Global Investment Conference, scheduled for September 14-16, 2026 at the Lotte New York Palace Hotel in New York City.

Chairman and CEO Virgilio Torres will deliver a live company presentation and hold one-on-one investor meetings

The enterprise virtual events technology firm, which operates through subsidiary Ten Events, Inc., is using the conference to update institutional investors on its 2026 growth strategy and capital allocation priorities. Torres said the appearance gives the company "a direct line to the investors who want to track that progress" on execution of the plan outlined to shareholders earlier this year.